Top ten biotechnologies for improving health in developing countries

被引：203

作者：

Daar, AS

Thorsteinsdóttir, H

Martin, DK

Smith, AC

Nast, S

Singer, PA

机构：

[1] Univ Toronto, Joint Ctr Bioeth, Toronto, ON M5G 1L4, Canada

[2] Univ Toronto, Program Appl Eth & Biotechnol, Toronto, ON M5G 1L4, Canada

[3] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M5G 1L4, Canada

[4] Univ Toronto, Dept Surg, Toronto, ON M5G 1L4, Canada

[5] Univ Toronto, Pan Amer Hlth Org, WHO, Collaborating Ctr Bioeth, Toronto, ON M5G 1L4, Canada

[6] Univ Toronto, Collaborat Program Bioeth, Toronto, ON M5G 1L4, Canada

[7] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5G 1L4, Canada

[8] Univ Toronto, Dept Med, Toronto, ON M5G 1L4, Canada

来源：

NATURE GENETICS | 2002年 / 32卷 / 02期

基金：

加拿大健康研究院;

关键词：

D O I：

10.1038/ng1002-229

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Most research into genomics and other related biotechnologies is concerned with the priorities of industrialized nations, and yet a limited number of projects have shown that these technologies could help improve health in developing countries. To encourage the successful application of biotechnology to global health, we carried out a study in which we asked an international group of eminent scientists with expertise in global health issues to identify the top ten biotechnologies for improving health in developing countries. The results offer concrete guidance to those in a position to influence the direction of research and development, and challenge common assumptions about the relevance and affordability of biotechnology for developing countries.

引用

页码：229 / 232

页数：4

共 30 条

[1] Evaluation of a new recombinant DNA hepatitis B vaccine (Shanvac-B) [J].

Abraham, P ;

Mistry, FP ;

Bapat, MR ;

Sharma, G ;

Reddy, GR ;

Prasad, KSN ;

Ramanna, T .

VACCINE, 1999, 17 (9-10) :1125-1129

[2]

Adler M., 1996, Gazing into the oracle

[3] Suitability of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus in Ghana, West Africa [J].

Aidoo, S ;

Ampofo, WK ;

Brandful, JAM ;

Nuvor, SV ;

Ansah, JK ;

Nii-Trebi, N ;

Barnor, JS ;

Apeagyei, F ;

Sata, T ;

Ofori-Adjei, D ;

Ishikawa, K .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (07) :2572-2575

[4]

[Anonymous], 2001, HUMAN DEV REPORT 200

[5]

[Anonymous], 2000, 10 90 REP HLTH RES 2

[6]

[Anonymous], 2001, MACROECONOMICS HLTH

[7] Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the field [J].

Beck, IA ;

Drennan, KD ;

Melvin, AJ ;

Mohan, KM ;

Herz, AM ;

Alarcón, J ;

Piscoya, J ;

Velázquez, C ;

Frenkel, LM .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (01) :29-33

[8] Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus type 1 vaccine with or without gp120: A phase 2 study in higher- and lower-risk volunteers [J].

Belshe, RB ;

Stevens, C ;

Gorse, GJ ;

Buchbinder, S ;

Weinhold, K ;

Sheppard, H ;

Stablein, D ;

Self, S ;

McNamara, J ;

Frey, S ;

Flores, J ;

Excler, JL ;

Klein, M ;

El Habib, R ;

Duliege, AM ;

Harro, C ;

Corey, L ;

Keefer, M ;

Mulligan, M ;

Wright, P ;

Celum, C ;

Judson, F ;

Mayer, K ;

McKirnan, D ;

Marmor, M ;

Woody, G .

JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (09) :1343-1352

[9] GenBank [J].

Benson, DA ;

Karsch-Mizrachi, I ;

Lipman, DJ ;

Ostell, J ;

Rapp, BA ;

Wheeler, DL .

NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :15-18

[10] Efficacy of RTS,S/ASO2 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia:: a randomised trial [J].

Bojang, KA ;

Milligan, PJM ;

Pinder, M ;

Vigneron, L ;

Alloueche, A ;

Kester, KE ;

Ballou, WR ;

Conway, DJ ;

Reece, WHH ;

Gothard, P ;

Yamuah, L ;

Delchambre, M ;

Voss, G ;

Greenwood, BM ;

Hill, A ;

McAdam, KPWJ ;

Tornieporth, N ;

Cohen, JD ;

Doherty, T .

LANCET, 2001, 358 (9297) :1927-1934

← 1 2 3 →